UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051690
Receipt number R000058989
Scientific Title A new assessment of postural vertical in the eyes closed and opened, and effects of vertical perception in Virtual Reality: an observational study and a randomized crossover trials
Date of disclosure of the study information 2023/07/23
Last modified on 2024/03/08 15:53:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A new assessment of postural vertical in the eyes closed and opened, and effects of vertical perception in Virtual Reality: an observational study and a randomized crossover trials

Acronym

A new assessment of postural vertical in the eyes closed and opened, and effects of vertical perception in Virtual Reality: an observational study and a randomized crossover trials

Scientific Title

A new assessment of postural vertical in the eyes closed and opened, and effects of vertical perception in Virtual Reality: an observational study and a randomized crossover trials

Scientific Title:Acronym

A new assessment of postural vertical in the eyes closed and opened, and effects of vertical perception in Virtual Reality: an observational study and a randomized crossover trials

Region

Japan


Condition

Condition

Healthy participants and stroke patients

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objectives of this research are to (1) develop an SPV evaluation and (2) determine what impact SPV has in Virtual Reality.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Others

Developmental phase

Phase I,II


Assessment

Primary outcomes

Evaluate SPV-EO and SPV using conventional motorized vertical perception measuring devices and digital angle meters (applications).

Key secondary outcomes

Trunk control test, functional in sitting test, berg balance test, functional independence measure, center of pressure


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Intervention of vertical cognition through visual feedback using VR

Interventions/Control_2

Visual and behavioral training using VR

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

19 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Participants meet the inclusion criteria of being able to sit when observing a person and having suffered their first stroke.

Key exclusion criteria

The exclusion criteria were as follows: brainstem lesions, cerebellar lesions, multiple cerebral infarctions, hydrocephalus, poor instruction comprehension, and orthopedic history.

Target sample size

52


Research contact person

Name of lead principal investigator

1st name Kota
Middle name
Last name Sawa

Organization

Ryotokuji University

Division name

Department of Physical Therapy, Faculty of Health Sciences

Zip code

2798567

Address

Akemi, Urayasu City, Chiba, 5-8-1

TEL

+818012079205

Email

koutas966@gmail.com


Public contact

Name of contact person

1st name Kota
Middle name
Last name Sawa

Organization

Ryotokuji University

Division name

Department of Physical Therapy, Faculty of Health Sciences

Zip code

2798567

Address

Akemi, Urayasu City, Chiba, 5-8-1

TEL

+818012079205

Homepage URL


Email

k-sawa@ryotokuji-u.ac.jp


Sponsor or person

Institute

Ryotokuji University

Institute

Department

Personal name



Funding Source

Organization

Ryotokuji University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ryotokuji University

Address

Akemi, Urayasu City, Chiba, 5-8-1

Tel

+818012079205

Email

k-sawa@ryotokuji-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 07 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 07 Month 23 Day

Date of IRB

2023 Year 07 Month 07 Day

Anticipated trial start date

2023 Year 07 Month 23 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry

2027 Year 03 Month 31 Day

Date trial data considered complete


Date analysis concluded

2027 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2023 Year 07 Month 22 Day

Last modified on

2024 Year 03 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058989


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name